The global intravascular catheters market size was estimated to be USD 0.667 billion in 2023 and is expected to reach at USD 1.79 billion by 2034 with a CAGR of 9.41% during the forecast period 2024-2034. Surge in incidence of chronic diseases such as cardiovascular disorders, neurological disorders, & urinary tract infections, increasing number of people being admitted to hospitals, growing quantity of outpatient care facilities & catheterization laboratories, rising utilization of catheters for less invasive diagnostic & interventional treatments, surge in need for sterile & high-quality catheters, the expanding quantity of catheterization laboratories, and increasing regulatory approvals of technologically advanced intravascular catheters are some of the key factors boosting the market growth.
Increasing regulatory approvals of technologically advanced intravascular catheters is predicted to boost the market growth during the forecast period. Intravascular catheters have evolved into an essential element of routine medical procedures and hold significant importance in intensive care units (ICUs). While their role in facilitating vascular access is vital, they also pose potential risks to patients in the form of various infectious complications, such as catheter-related bloodstream infections (CRBSI), local site infections, endocarditis, septic thrombophlebitis, and other systemic infections. Hence, it is anticipated that advancements in technology will reduce the occurrence of these infections, leading to a heightened demand for these catheters in the coming years. For instance, in February 2023, Northeast Scientific Inc, a company specializing in the reprocessing of single-use peripheral vascular catheters, has obtained FDA 510(k) clearance for reprocessing the Philips IVUS Eagle Eye Platinum RX Digital Catheter.
By product, short peripheral intravenous catheters was the highest revenue-grossing segment in the global intravascular catheters market in 2023 owing to the reduced occurrence of infections related to these peripheral intravenous catheters (PIVCs), growing prevalence of cardiovascular, neurological, oncological, & gastroenterological diseases, and increasing involvement of market participants in expanding their product offerings. Additionally, integrated peripheral intravenous catheters is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of chronic diseases, surge in investment in research & development activities, and growing focus on the introduction of novel medical devices. For instance, in November 2023, BD (Becton, Dickinson and Company) has introduced an innovative needle-free blood draw technology that is compatible with integrated catheters, aligning with the company's objective of a "One-Stick Hospital Stay." This new device, the PIVO Pro Needle-free Blood Collection Device, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Notably, it is the first and only device designed to be compatible with integrated and extended peripheral IV catheters, including the new Nexiva Closed IV Catheter System with NearPort IV Access.
By application, others was the highest revenue-grossing segment in the global intravascular catheters market in 2023 owing to the surge in incidence of trauma & other chronic diseases such cardiovascular & urological, & other diseases and increasing regulatory approvals of novel devices. For instance, in January 2023, Infinity Neuro's Inspira Aspiration Catheters have received CE Mark approval and are now ready for commercialization in Europe. These catheters are designed to provide advanced navigation and aspiration capabilities, allowing for easy access to targeted blood vessels, swift restoration of cerebral blood flow, and the retrieval of clots in patients suffering from acute ischemic stroke (AIS) caused by large vessel occlusion (LVO). Additionally, infectious diseases is predicted to grow at fastest CAGR during the forecast period owing to growing prevalence of infectious diseases including HIV, tuberculosis, & HPV and a significant increase in hospital admissions & other healthcare providers.
By end-user, hospitals was the highest revenue-grossing segment in the global intravascular catheters market in 2023 owing to a substantial volume of surgical procedures being conducted to treat cardiovascular, gastroenterology, renal, & various infectious diseases and surge in introduction of advanced devices. For instance, in July 2022, Intravascular Imaging Incorporated has introduced its 3 Fr NIRF-IVUS (Near-Infrared Fluorescence Intravascular Ultrasound) imaging catheter for coronary imaging in humans. This catheter was developed and subjected to ex-vivo testing in human coronary arteries and in vivo evaluation in preclinical studies in partnership with Massachusetts General Hospital. Additionally, ambulatory surgical centers (ASC) is predicted to grow at fastest CAGR during the forecast period owing to the forecast period. Ambulatory Surgical Centers (ASCs) are autonomous healthcare facilities dedicated to delivering outpatient surgical care. They generally have lower surgical costs compared to hospitals. Furthermore, ASCs are comparatively cleaner and safer than hospitals, leading to fewer infections. These factors, in addition to the rising prevalence of cardiovascular, neurological, oncological, and gastroenterological diseases, contribute to the increasing prominence of ASCs.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising prevalence of chronic diseases, increasing product approvals, surge in in hospital admissions necessitating treatments involving vascular catheterization & accessing veins, growing focus on product innovations, and rising launch of new devices. For instance, in April 2022, Shockwave Medical, a company based in California, has introduced its Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter following the receipt of both a CE mark and clearance from the Food and Drug Administration (FDA). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of oncological disorders, infectious, renal, & urological diseases, growing inpatient & emergency room medical procedures, surge in launch of new products, and rising technological advancements. For instance, in September 2022, Wipro GE Healthcare has introduced the 'Made in India' AI-powered Cath lab, named Optima IGS 320, aimed at enhancing cardiac care in India. This system harnesses GE's proprietary AutoRight technology, which is the first neural network-based interventional image chain featuring artificial intelligence. It autonomously optimizes image and dose parameters in real time.
Increasing regulatory approvals of technologically advanced intravascular catheters is predicted to boost the market growth during the forecast period. Intravascular catheters have evolved into an essential element of routine medical procedures and hold significant importance in intensive care units (ICUs). While their role in facilitating vascular access is vital, they also pose potential risks to patients in the form of various infectious complications, such as catheter-related bloodstream infections (CRBSI), local site infections, endocarditis, septic thrombophlebitis, and other systemic infections. Hence, it is anticipated that advancements in technology will reduce the occurrence of these infections, leading to a heightened demand for these catheters in the coming years. For instance, in February 2023, Northeast Scientific Inc, a company specializing in the reprocessing of single-use peripheral vascular catheters, has obtained FDA 510(k) clearance for reprocessing the Philips IVUS Eagle Eye Platinum RX Digital Catheter.
By product, short peripheral intravenous catheters was the highest revenue-grossing segment in the global intravascular catheters market in 2023 owing to the reduced occurrence of infections related to these peripheral intravenous catheters (PIVCs), growing prevalence of cardiovascular, neurological, oncological, & gastroenterological diseases, and increasing involvement of market participants in expanding their product offerings. Additionally, integrated peripheral intravenous catheters is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of chronic diseases, surge in investment in research & development activities, and growing focus on the introduction of novel medical devices. For instance, in November 2023, BD (Becton, Dickinson and Company) has introduced an innovative needle-free blood draw technology that is compatible with integrated catheters, aligning with the company's objective of a "One-Stick Hospital Stay." This new device, the PIVO Pro Needle-free Blood Collection Device, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Notably, it is the first and only device designed to be compatible with integrated and extended peripheral IV catheters, including the new Nexiva Closed IV Catheter System with NearPort IV Access.
By application, others was the highest revenue-grossing segment in the global intravascular catheters market in 2023 owing to the surge in incidence of trauma & other chronic diseases such cardiovascular & urological, & other diseases and increasing regulatory approvals of novel devices. For instance, in January 2023, Infinity Neuro's Inspira Aspiration Catheters have received CE Mark approval and are now ready for commercialization in Europe. These catheters are designed to provide advanced navigation and aspiration capabilities, allowing for easy access to targeted blood vessels, swift restoration of cerebral blood flow, and the retrieval of clots in patients suffering from acute ischemic stroke (AIS) caused by large vessel occlusion (LVO). Additionally, infectious diseases is predicted to grow at fastest CAGR during the forecast period owing to growing prevalence of infectious diseases including HIV, tuberculosis, & HPV and a significant increase in hospital admissions & other healthcare providers.
By end-user, hospitals was the highest revenue-grossing segment in the global intravascular catheters market in 2023 owing to a substantial volume of surgical procedures being conducted to treat cardiovascular, gastroenterology, renal, & various infectious diseases and surge in introduction of advanced devices. For instance, in July 2022, Intravascular Imaging Incorporated has introduced its 3 Fr NIRF-IVUS (Near-Infrared Fluorescence Intravascular Ultrasound) imaging catheter for coronary imaging in humans. This catheter was developed and subjected to ex-vivo testing in human coronary arteries and in vivo evaluation in preclinical studies in partnership with Massachusetts General Hospital. Additionally, ambulatory surgical centers (ASC) is predicted to grow at fastest CAGR during the forecast period owing to the forecast period. Ambulatory Surgical Centers (ASCs) are autonomous healthcare facilities dedicated to delivering outpatient surgical care. They generally have lower surgical costs compared to hospitals. Furthermore, ASCs are comparatively cleaner and safer than hospitals, leading to fewer infections. These factors, in addition to the rising prevalence of cardiovascular, neurological, oncological, and gastroenterological diseases, contribute to the increasing prominence of ASCs.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising prevalence of chronic diseases, increasing product approvals, surge in in hospital admissions necessitating treatments involving vascular catheterization & accessing veins, growing focus on product innovations, and rising launch of new devices. For instance, in April 2022, Shockwave Medical, a company based in California, has introduced its Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter following the receipt of both a CE mark and clearance from the Food and Drug Administration (FDA). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of oncological disorders, infectious, renal, & urological diseases, growing inpatient & emergency room medical procedures, surge in launch of new products, and rising technological advancements. For instance, in September 2022, Wipro GE Healthcare has introduced the 'Made in India' AI-powered Cath lab, named Optima IGS 320, aimed at enhancing cardiac care in India. This system harnesses GE's proprietary AutoRight technology, which is the first neural network-based interventional image chain featuring artificial intelligence. It autonomously optimizes image and dose parameters in real time.
Segmentation: Intravascular Catheters Market Report 2023 - 2034
Intravascular Catheters Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Integrated Peripheral Intravenous Catheters
- Short Peripheral Intravenous Catheters
Intravascular Catheters Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Infectious Diseases
- Oncology
- Renal Disease
- Gastroenterology
- Others
Intravascular Catheters Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Clinics
- Hospitals
- Homecare
- Ambulatory Surgical Centers (ASC)
- Others
Intravascular Catheters Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Intravascular Catheters Market: Product Estimates & Trend Analysis
8. Intravascular Catheters Market: Application Estimates & Trend Analysis
9. Intravascular Catheters Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Intravascular Catheters Market
12. Europe Global Intravascular Catheters Market
13. Asia Pacific Global Intravascular Catheters Market
14. Latin America Global Intravascular Catheters Market
15. MEA Global Intravascular Catheters Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Edwards Lifesciences Corporation
- Cook
- BD
- Medtronic
- Abbott
- Boston Scientific Corporation
- McKesson Medical-Surgical
- Getinge AB
- Terumo Corporation
- Conavi Medical
- Coloplast Corp
- Smith & Nephew plc
- Johnson & Johnson Private Limited
- Infraredx Inc.
- Cardinal Health
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.67 Billion |
| Forecasted Market Value ( USD | $ 1.79 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
